Status
Conditions
About
Patients aged 75 and over represent a heterogeneous population with fragile subjects who have a higher risk of poor tolerance to many tests and especially who have a risk of major functional loss in the event of hospitalization. It is therefore necessary to adapt our prescriptions and not to impose on these patients an examination that is unnecessary. Or on the contrary, not to do without, out of ignorance, a minimally invasive examination that could be useful to these patients.
In this study, the investigators wish to evaluate the interest of the Pet-Scan in the therapeutic management of these elderly patients
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Translated with www.DeepL.com/Translator
Loading...
Central trial contact
Carole GREUEZ, MD; Emmanuel ANDRES, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal